Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0020538 (
hypertension
)
170,190
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Overweight and obesity
have become a frequent phenomenon among pregnant women during last thirty years. They result in increased morbidity rates of different chronic, health- or even life-threatening diseases. Among different perinatal complications associated with obesity the most important are:
hypertension
, diabetes, varices, cholecystolithiasis, prolonged pregnancy, intrauterine growth retardation. Increased rates of operative deliveries, intrapartal and postpartal infections, thrombotic complications, anaemia, urinary infections and lactation disorders can be observed.
...
PMID:[Overweight and obesity as the risk factor in perinatology]. 1188 35
This study was undertaken to assess the recent data on Malaysian adult body weights and associations of ethnic differences in overweight and obesity with comorbid risk factors, and to examine measures of energy intake, energy expenditure, basal metabolic rate (BMR) and physical activity changes in urban and rural populations of normal weight. Three studies were included (1) a summary of a national health morbidity survey conducted in 1996 on nearly 29 000 adults > or =20 years of age; (2) a study comparing energy intake, BMR and physical activity levels (PALs) in 409 ethnically diverse, healthy adults drawn from a population of 1165 rural and urban subjects 18-60 years of age; and (3) an examination of the prevalence of obesity and comorbid risk factors that predict coronary heart disease and type 2 diabetes in 609 rural Malaysians aged 30-65 years.
Overweight and obesity
were calculated using body mass index (BMI) measures and World Health Organization (WHO) criteria. Energy intake was assessed using 3-d food records, BMR and PALs were assessed with Douglas bags and activity diaries, while
hypertension
, hyperlipidaemia and glucose intolerance were specified using standard criteria. The National Health Morbidity Survey data revealed that in adults, 20.7% were overweight and 5.8% obese (0.3% of whom had BMI values of >40.0 kg m(-2)); the prevalence of obesity was clearly greater in women than in men. In women, obesity rates were higher in Indian and Malay women than in Chinese women, while in men the Chinese recorded the highest obesity prevalences followed by the Malay and Indians. Studies on normal healthy subjects indicated that the energy intake of Indians was significantly lower than that of other ethnic groups. In women, Malays recorded a significantly higher energy intake than the other groups. Urban male subjects consumed significantly more energy than their rural counterparts, but this was not the case in women. In both men and women, fat intakes (%) were significantly higher in Chinese and urban subjects. Men were moderately active with the exception of the Dayaks. Chinese women were considerably less active than Chinese men. Chinese and Dayak women were less active than Malay and Indian women. In both men and women, Indians recorded the highest PALs. Hence, current nutrition and health surveys reveal that Malaysians are already affected by western health problems. The escalation of obesity, once thought to be an urban phenomenon, has now spread to the rural population at an alarming rate. As Malaysia proceeds rapidly towards a developed economy status, the health of its population will probably continue to deteriorate. Therefore, a national strategy needs to be developed to tackle both dietary and activity contributors to the excess weight gain of the Malaysian population.
...
PMID:Obesity in Malaysia. 1216 73
The prevalence of marked obesity is increasing rapidly among adults and has more than doubled in 10 years. Sixty-one percent of the adult population of the United States is overweight or obese. Americans are the fattest people on earth. Paradoxically these increases in the numbers of persons who are obese or overweight have occurred during recent years when Americans have been preoccupied with numerous dietary programs, diet products, weight control, health clubs, home exercise equipment, and physical fitness videos, each "guaranteed" to bring rapid results.
Overweight and obesity
are also world problems. The World Health Organization estimates that 1 billion people around the world are now overweight or obese. Westernization of diets has been part of the problem. Fruits, vegetables, and whole grains are being replaced by readily accessible foods high in saturated fat, sugar, and refined carbohydrates. Since class 3 obesity (morbid or extreme obesity) is associated with the most severe health complications, the incidence of
hypertension
, stroke, heart disease, diabetes, and peripheral vascular disease will increase substantially in the future. Recently, obesity alone has been implicated in the development of cardiac hypertrophy and CHF. The metabolic syndrome associated with abdominal obesity, which includes insulin resistance, dyslipidemia, and elevated CRP levels, identifies subjects who have an increase in cardiovascular morbidity and mortality. Twenty to 25% of the adult population in the United States have the metabolic syndrome, and in some older groups this prevalence approaches 50%. The prevalence of overweight children in the United States has also been increasing dramatically, especially among non-Hispanic blacks and Mexican-American adolescents. Overweight children usually become overweight adults. Atherosclerosis begins in childhood. The degree of atherosclerotic changes in children and young adults can be correlated with the presence of the same risk factors seen in adults. As health providers, our direction is obvious!
...
PMID:Obesity and the metabolic syndrome. 1262 76
Overweight and obesity
have become an urgent public health problem in the United States: approximately 61% of the adult population (97 million adults) are overweight or obese, where overweight is defined as a body mass index (BMI) >/= 25 and obesity is defined as a BMI >/= 30.
Overweight and obesity
increase the risk for developing many serious chronic diseases such as cardiovascular disease, type 2 diabetes,
hypertension
, dyslipidemia, and certain cancers. Increased morbidity due to obesity-related disorders begins within the normal weight range. Weight gain in adulthood per se, even in individuals who are normal weight, has deleterious health effects. Medications, particularly those commonly used in psychiatry and neurology, are a significant iatrogenic source of overweight and obesity. The weight gain potential of prescription medications should be considered in order to enhance patient compliance and reduce the risk of metabolic sequelae of weight gain. This article provides an overview of the weight-gain potential of several classes of drugs commonly used in psychiatric practice and considerations for clinicians in prescribing these medications.
...
PMID:Weight gain in the treatment of mood disorders. 1289 38
Obesity has become an epidemic problem in western societies, contributing to metabolic diseases,
hypertension
, and cardiovascular disease.
Overweight and obesity
are frequently associated with increased plasma levels of aldosterone. Recent evidence suggests that human fat is a highly active endocrine tissue. Therefore, we tested the hypothesis that adipocyte secretory products directly stimulate adrenocortical aldosterone secretion. Secretory products from isolated human adipocytes strongly stimulated steroidogenesis in human adrenocortical cells (NCI-H295R) with a predominant effect on mineralocorticoid secretion. Aldosterone secretion increased 7-fold during 24 h of incubation. This stimulation was comparable to maximal stimulation of these cells with forskolin (2 x 10(-5) M). On the molecular level, there was a 10-fold increase in the expression of steroid acute regulatory peptide mRNA. This effect was independent of adipose angiotensin II as revealed by the stimulatory effect of fat cell-conditioned medium even in the presence of the angiotensin type 1 receptor antagonist, valsartan. None of the recently defined adipocytokines accounted for the effect. Mineralocorticoid-stimulating activity was heat sensitive and could be blunted by heating fat cell-conditioned medium to 99 degrees C. Centrifugal filtration based on molecular mass revealed at least two releasing factors: a heat sensitive fraction (molecular mass >50 kDa) representing 60% of total activity, and an inactive fraction (molecular mass <50 kDa). However, the recovery rate increased to 92% when combining these two fractions, indicating the interaction of at least two factors. In conclusion, human adipocytes secrete potent mineralocorticoid-releasing factors, suggesting a direct link between obesity and
hypertension
.
...
PMID:Human adipocytes secrete mineralocorticoid-releasing factors. 1461 37
Two recently published reports from American Heart Association and National Heart, Lung, and Blood Institute have addressed the management of the metabolic syndrome. It is of importance to present the content of these reports and to discuss the management of the metabolic syndrome in Swedish health care. Today there are official definitions of the metabolic syndrome from the US and also definitions issued by the WHO. The American criteria have been developed with the aim to be used in clinical practice whereas the definitions from the WHO are partly based upon examinations, which are not routinely used in the routine care. The metabolic syndrome is common among men and women and increases in parallel with increasing age.
Overweight and obesity
are among the most important factors in the syndrome, which may be expected to increase because of the increasing incidence of obesity. The metabolic syndrome according to the two definitions has in several studies been shown to strongly increase the risk for type 2 diabetes and are also associated with an increased risk of cardiovascular disease and death. Treatment of the syndrome must first of all be focused on changing diet and physical exercise habits. Drug therapy can be used for individual components in the syndrome such as
hypertension
, dyslipidemia, and hyperglycemia. Although there is still a need of further research in order to develop the knowledge of underlying mechanisms, improve risk assessment and treatment, there are now sufficient data and experiences to introduce the concept of the metabolic syndrome in clinical practice in the Swedish health care.
...
PMID:[The metabolic syndrome--time to introduce the diagnosis in routine health care? Reflections on a current American report]. 1563 Dec 25
In excess of 50% of adult population and nearly one third of children in Mexico have overweight and obesity. This accounts for slightly >32,671,000 million persons, excluding children; thus, total numbers are even more significant. These figures are alarming for those responsible for the economic future and well-being of Mexico.
Overweight and obesity
lead to higher risk of mortality as well as development of multiple diseases, mainly coronary heart disease, diabetes type 2, cancer, and stroke, which are at present the principal causes of mortality in Mexico. The World Health Organization (WHO) announced that there are throughout the world more than one billion adults with overweight, of whom 300 million have obesity. In addition to the obesity epidemic in Mexico, there is high prevalence of diabetes type 2. Coexistence of both epidemics has been denominated the twin epidemic. As many as 80% of cases of type 2 diabetes are linked with overweight or obesity, particularly abdominal obesity. The disease was once thought to be limited to adults, but obese children are now developing the illness. In Mexico, we are able to refer to at least three epidemics, because not only are obesity and type 2 diabetes advancing rapidly in the country, but also cardiovascular disease, linked with high prevalence of both
hypertension
and metabolic syndrome as reported by scientists based on Mexican National Health Survey 2000 data.
...
PMID:[The epidemiology of obesity]. 1564 67
Obesity has become an epidemic problem in Western societies contributing to several disease processes including metabolic diseases,
hypertension
, and cardiovascular disease.
Overweight and obesity
are frequently associated with increased plasma levels of aldosterone suggesting a direct link between obesity
hypertension
and increased mineralocorticoid levels. The adipocyte has long been suggested to be directly involved in the regulation of the body's homeostasis and recent evidence now proves that human fat is a highly active endocrine tissue. We therefore tested the hypothesis that adipocyte secretory products directly stimulate adrenocortical aldosterone secretion. Indeed, secretory products from isolated human adipocytes strongly stimulated steroidogenesis in human adrenocortical cells (NCI-H295R), as well as in bovine adrenocortical cells with a predominant effect on mineralocorticoid secretion. In conclusion, a possible direct link exists between fat tissue metabolism and adrenal mineralocorticoid secretion that may be responsible for obesity-related
hypertension
.
...
PMID:Fat cells may be the obesity-hypertension link: human adipogenic factors stimulate aldosterone secretion from adrenocortical cells. 1566 38
Childhood obesity is considered pandemic with significant social and economical costs because of its high morbidity and mortality. To evaluate the association between biological and environmental factors and infantile arterial
hypertension
(AH), a cross-sectional study was performed with 701 children, ranging from 5 to 9 years old, from Feira de Santana, BA. The arterial pressure was measured following the criteria of the Update on the 1987 Task Force Report on
High Blood Pressure
in Children and Adolescents.
Overweight and obesity
were defined as body-mass index equal or above the 85th and the 95th percentiles for age and gender, respectively. Interviews with the children's responsible were used to determine the role of gender, ethnic group, age, familiar history of AH, and type of school. Overweight (OR= 4.49; rho= 0.04), obesity (OR= 13.05; rho= 0.000) and studying at private school (OR= 1.93; r= 0.13) were observed as predictive and independent factors associated with
hypertension
. Therefore, biological and environmental factors seem to be involved on the genesis of AH in children.
...
PMID:[Environmental and anthropometric factors associated with childhood arterial hypertension]. 1576 59
Body mass index (BMI) should be assessed at every health care visit.
Overweight and obesity
are associated with higher risks of
hypertension
, type 2 diabetes, irregular ovulation, infertility, and pregnancy and birth complications. Family planning and annual gynecology examinations give primary care providers the opportunity to share basic weight management guidelines with women. Weight management to normalize BMI or reduce overweight and obesity is vital to reduce future comorbidities. This article demonstrates integration of basic weight management into gynecologic care.
...
PMID:Weight management in gynecologic care. 1615 72
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>